Drug firm Jubilant Life Sciences Ltd today said its consolidated net profit stood at Rs 125.47 crore for the second quarter ended September 30.
The company had posted Rs 143.56 crore net profit after tax for the corresponding period of the previous fiscal, Jubilant Life Sciences said in a filing to BSE.
The company also said that sales/incomes from operations for the current period is not comparable with previous periods, due to Goods and Services Tax (GST) implementation.
Consolidated total income from operations stood at Rs 1649.13 crore in the quarter under review.
Pharmaceuticals revenue was at Rs 860 crore, contributing 52 per cent to the revenues. Life Science ingredients revenue was at Rs 738 crore, representing 45 per of the revenues, the company said.
International revenues were at Rs 1,181 crore, constituting 72 per cent of the revenue for the quarter,it added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
